563 related articles for article (PubMed ID: 29027562)
1. Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii) polypyridyl complexes as anticancer drug candidates.
Notaro A; Gasser G
Chem Soc Rev; 2017 Nov; 46(23):7317-7337. PubMed ID: 29027562
[TBL] [Abstract][Full Text] [Related]
2. New ruthenium polypyridyl complexes functionalized with fluorine atom or furan: Synthesis, DNA-binding, cytotoxicity and antitumor mechanism studies.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Feb; 227():117534. PubMed ID: 31685424
[TBL] [Abstract][Full Text] [Related]
3. Bifunctional ruthenium(ii) polypyridyl complexes of curcumin as potential anticancer agents.
Li S; Xu G; Zhu Y; Zhao J; Gou S
Dalton Trans; 2020 Jul; 49(27):9454-9463. PubMed ID: 32598409
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of action of Ru(ii) polypyridyl complexes in living cells upon light irradiation.
Jakubaszek M; Goud B; Ferrari S; Gasser G
Chem Commun (Camb); 2018 Nov; 54(93):13040-13059. PubMed ID: 30398487
[TBL] [Abstract][Full Text] [Related]
5. Impact of aromaticity on anticancer activity of polypyridyl ruthenium(II) complexes: synthesis, structure, DNA/protein binding, lipophilicity and anticancer activity.
Čanović P; Simović AR; Radisavljević S; Bratsos I; Demitri N; Mitrović M; Zelen I; Bugarčić ŽD
J Biol Inorg Chem; 2017 Oct; 22(7):1007-1028. PubMed ID: 28695374
[TBL] [Abstract][Full Text] [Related]
6. Development of four ruthenium polypyridyl complexes as antitumor agents: Design, biological evaluation and mechanism investigation.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
J Inorg Biochem; 2020 Jul; 208():111104. PubMed ID: 32485635
[TBL] [Abstract][Full Text] [Related]
7. Unexplored features of Ru(ii) polypyridyl complexes - towards combined cytotoxic and antimetastatic activity.
Gurgul I; Mazuryk O; Łomzik M; Gros PC; Rutkowska-Zbik D; Brindell M
Metallomics; 2020 May; 12(5):784-793. PubMed ID: 32227043
[TBL] [Abstract][Full Text] [Related]
8. A novel ruthenium(II)-polypyridyl complex inhibits cell proliferation and induces cell apoptosis by impairing DNA damage repair.
Yang Q; Zhang Z; Mei W; Sun F
J Chemother; 2014 Aug; 26(4):235-42. PubMed ID: 24070188
[TBL] [Abstract][Full Text] [Related]
9. The biological effect of the nitroimidazole derivative of a polypyridyl ruthenium complex on cancer and endothelial cells.
Mazuryk O; Suzenet F; Kieda C; Brindell M
Metallomics; 2015 Mar; 7(3):553-66. PubMed ID: 25711770
[TBL] [Abstract][Full Text] [Related]
10. Detailed account on activation mechanisms of ruthenium coordination complexes and their role as antineoplastic agents.
Pal M; Nandi U; Mukherjee D
Eur J Med Chem; 2018 Apr; 150():419-445. PubMed ID: 29547831
[TBL] [Abstract][Full Text] [Related]
11. A nuclear permeable Ru(ii)-based photoactivated chemotherapeutic agent towards a series of cancer cells: in vitro and in vivo studies.
Tian N; Feng Y; Sun W; Lu J; Lu S; Yao Y; Li C; Wang X; Zhou Q
Dalton Trans; 2019 May; 48(19):6492-6500. PubMed ID: 30994660
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial fragmentation is an important cellular event induced by ruthenium(II) polypyridyl complexes in osteosarcoma cells.
Du Y; Fu X; Li H; Chen B; Guo Y; Su G; Zhang H; Ning F; Lin Y; Mei W; Chen T
ChemMedChem; 2014 Apr; 9(4):714-8. PubMed ID: 24403015
[TBL] [Abstract][Full Text] [Related]
13. Ruthenium(II) polypyridyl complexes: cellular uptake, cell image and apoptosis of HeLa cancer cells induced by double targets.
Yu Q; Liu Y; Xu L; Zheng C; Le F; Qin X; Liu Y; Liu J
Eur J Med Chem; 2014 Jul; 82():82-95. PubMed ID: 24878637
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic Ruthenium(II) Complexes Containing a Dangling Pyridine: Selectivity for Diseased Cells Mediated by pH-Dependent DNA Binding.
Sangeetha S; Murali M
Inorg Chem; 2022 Feb; 61(6):2864-2882. PubMed ID: 35099196
[TBL] [Abstract][Full Text] [Related]
15. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.
Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q
Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972
[TBL] [Abstract][Full Text] [Related]
16. Half-sandwich ruthenium(ii) complexes containing N^N-chelated imino-pyridyl ligands that are selectively toxic to cancer cells.
Tian M; Li J; Zhang S; Guo L; He X; Kong D; Zhang H; Liu Z
Chem Commun (Camb); 2017 Nov; 53(95):12810-12813. PubMed ID: 29143019
[TBL] [Abstract][Full Text] [Related]
17. Synthetic strategies towards ruthenium-porphyrin conjugates for anticancer activity.
Gianferrara T; Bratsos I; Iengo E; Milani B; Ostrić A; Spagnul C; Zangrando E; Alessio E
Dalton Trans; 2009 Dec; (48):10742-56. PubMed ID: 20023904
[TBL] [Abstract][Full Text] [Related]
18. Increased Lipophilicity of Halogenated Ruthenium(II) Polypyridyl Complexes Leads to Decreased Phototoxicity in vitro when Used as Photosensitizers for Photodynamic Therapy.
Roy S; Colombo E; Vinck R; Mari C; Rubbiani R; Patra M; Gasser G
Chembiochem; 2020 Oct; 21(20):2966-2973. PubMed ID: 32473056
[TBL] [Abstract][Full Text] [Related]
19. Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives.
Lee SY; Kim CY; Nam TG
Drug Des Devel Ther; 2020; 14():5375-5392. PubMed ID: 33299303
[TBL] [Abstract][Full Text] [Related]
20. Systematic investigation of the antiproliferative activity of a series of ruthenium terpyridine complexes.
Karges J; Blacque O; Jakubaszek M; Goud B; Goldner P; Gasser G
J Inorg Biochem; 2019 Sep; 198():110752. PubMed ID: 31242458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
